Page last updated: 2024-08-24

2-oxindole and Astrocytoma, Grade IV

2-oxindole has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borghini, A; Breschi, MC; Calderone, V; Daniele, S; Digiacomo, M; Falasca, M; Lapucci, A; Macchia, M; Martelli, A; Martini, C; Nesi, G; Notarangelo, A; Parrella, P; Pietra, D; Rapposelli, S; Sestito, S1

Other Studies

1 other study(ies) available for 2-oxindole and Astrocytoma, Grade IV

ArticleYear
Design and synthesis of 2-oxindole based multi-targeted inhibitors of PDK1/Akt signaling pathway for the treatment of glioblastoma multiforme.
    European journal of medicinal chemistry, 2015, Nov-13, Volume: 105

    Topics: Cell Count; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Glioblastoma; Humans; Indoles; Molecular Structure; Oxindoles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Structure-Activity Relationship

2015